Literature DB >> 8045596

Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules.

D I Gabrilovich1, G M Woods, S Patterson, J J Harvey, S C Knight.   

Abstract

Dendritic cells (DC) within tissues may acquire and process antigens, carry them into lymph nodes and cluster and activate T cells. The ability of DC to acquire antigen and to migrate to lymph nodes was estimated during murine retroviral infection caused by Rauscher leukaemia virus (RLV). A novel mechanism of inducing immunodeficiency has now been identified. In mice infected with RLV, DC failed to migrate into lymph nodes following exposure of the skin to the contact sensitizer, fluorescein isothiocyanate. RLV infection of a proportion of DC both in skin and lymph nodes, shown by semi-quantitative polymerase chain reaction (PCR) and down-regulation of expression of adhesion molecules (CD54 and CD44) on the surface of Langerhans' cells, may contribute to the described phenomenon. A failure of DC migration could be an important immunosuppressive mechanism of RLV infection in mice and we speculate on a similar role for DC in human immunodeficiency virus-1 (HIV-1) infection in humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045596      PMCID: PMC1414836     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

Review 1.  Retrovirus-induced acquired immunodeficiencies.

Authors:  M Bendinelli; D Matteucci; H Friedman
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

2.  Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer.

Authors:  G L Asherson; W Ptak
Journal:  Immunology       Date:  1968-09       Impact factor: 7.397

3.  Rapid cell culture assay technic for murine leukaemia viruses.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Nature       Date:  1971-02-19       Impact factor: 49.962

4.  A monoclonal antibody specific for mouse dendritic cells.

Authors:  M C Nussenzweig; R M Steinman; M D Witmer; B Gutchinov
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

6.  Demonstration of the absence of infectious Rous virus in rat tumour XC, whose structurally intact cells produce Rous sarcoma when transferred to chicks.

Authors:  J SVOBODA; P CHYLE; D SIMKOVIC; I HILGERT
Journal:  Folia Biol (Praha)       Date:  1963-04       Impact factor: 0.906

7.  The role of dendritic cells in the initiation of immune responses to contact sensitizers. I. In vivo exposure to antigen.

Authors:  S C Knight; J Krejci; M Malkovsky; V Colizzi; A Gautam; G L Asherson
Journal:  Cell Immunol       Date:  1985-09       Impact factor: 4.868

8.  EDTA separation and ATPase Langerhans cell staining in the mouse epidermis.

Authors:  K W Baker; J E Habowsky
Journal:  J Invest Dermatol       Date:  1983-02       Impact factor: 8.551

9.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

10.  Carcinogen-induced depletion of cutaneous Langerhans cells.

Authors:  H K Muller; G M Halliday; B A Knight
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

View more
  8 in total

1.  Acquisition of immune function during the development of the Langerhans cell network in neonatal mice.

Authors:  A L Dewar; K V Doherty; G M Woods; A B Lyons; H K Muller
Journal:  Immunology       Date:  2001-05       Impact factor: 7.397

Review 2.  Molecular immunopathogenesis of HIV infection.

Authors:  T T Ng; A J Pinching; C Guntermann; W J Morrow
Journal:  Genitourin Med       Date:  1996-12

3.  Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes.

Authors:  A D Lucas; G M Halliday
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion.

Authors:  G M Woods; M Qu; S J Ragg; H K Muller
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

5.  Adhesion molecule expression by epidermal Langerhans cells and lymph node dendritic cells: a comparison.

Authors:  M Cumberbatch; R J Dearman; I Kimber
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

6.  Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization.

Authors:  M Cumberbatch; I Kimber
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

7.  Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection.

Authors:  V Angeli; C Faveeuw; O Roye; J Fontaine; E Teissier; A Capron; I Wolowczuk; M Capron; F Trottein
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

8.  Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells.

Authors:  Myrna L Ortiz; Vinit Kumar; Anna Martner; Sridevi Mony; Laxminarasimha Donthireddy; Thomas Condamine; John Seykora; Stella C Knight; George Malietzis; Gui Han Lee; Morgan Moorghen; Brianna Lenox; Noreen Luetteke; Esteban Celis; Dmitry Gabrilovich
Journal:  J Exp Med       Date:  2015-02-09       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.